Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer

Epigenetics

Volumn 11, Issue 8, 2016, Pages 588-602

  Galamb, Orsolya ^a   Kalmár, Alexandra ^b   Péterfia, Bálint ^b   Csabai, István ^c   Bodor, András ^c   Ribli, Dezső ^c   Krenács, Tibor ^a,b   Patai, Árpád V ^b   Wichmann, Barnabás ^a   Barták, Barbara Kinga ^b   Tóth, Kinga ^b   Valcz, Gábor ^a   Spisák, Sándor ^d   Tulassay, Zsolt ^a,b   Molnár, Béla ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Adenoma; APC; colorectal cancer; gene expression; promoter and gene body methylation; whole methylome analysis; WNT signaling pathway; catenin mutation

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; AXIN2 GENE; CACYBP GENE; CANCER GROWTH; CHP1 GENE; COLORECTAL CANCER; CONTROLLED STUDY; CTNNB1 GENE; DKK1 GENE; DNA ISOLATION; DNA METHYLATION; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; MUTATIONAL ANALYSIS; ONCOGENE MYC; POLYMERASE CHAIN REACTION; PRICKLE1 GENE; PROMOTER REGION; SEQUENCE ANALYSIS; SFRP1 GENE; SFRP2 GENE; SOX17 GENE; TUMOR LOCALIZATION; VANGL1 GENE; WNT SIGNALING PATHWAY; WNT5A GENE; COLORECTAL TUMOR; GENE LOCUS; GENETICS; HUMAN GENOME; METABOLISM; PATHOLOGY;

TUMOR MARKER;

ADENOMA; AGED; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GENETIC LOCI; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; WNT SIGNALING PATHWAY;

EID: 84976532755     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2016.1190894     Document Type: Article

References (66)

1. GLOBOCAN 2012. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 2012. http://globocan.iarc.fr/Pages/online.aspx
2. M.Pancione, A.Remo, V.Colantuoni. Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog Res Int 2012; 2012:509348; PMID:22888469; http://dx.doi.org/10.1155/2012/509348
3. F.Sipos, G.Mũzes, A.V.Patai, I.Fũri, B.Péterfia, P.Hollósi, B.Molnár, Z.Tulassay. Genome-wide screening for understanding the role of DNA methylation in colorectal cancer. Epigenomics 2013; 5:569-81; PMID:24059802; http://dx.doi.org/10.2217/epi.13.52
4. A.V.Patai, B.Molnár, A.Kalmár, A.Schöller, K.Tóth, Z.Tulassay. Role of DNA methylation in colorectal carcinogenesis. Dig Dis 2012; 30:310-5; PMID:22722557; http://dx.doi.org/10.1159/000337004
5. M.S.Kim, J.Lee, D.Sidransky. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 2010; 29:181-206; PMID:20135198; http://dx.doi.org/10.1007/s10555-010-9207-6
6. A.V.Patai, B.Molnár, Z.Tulassay, F.Sipos. Serrated pathway:alternative route to colorectal cancer. World J Gastroenterol 2013; 19:607-15; PMID:23431044; http://dx.doi.org/10.3748/wjg.v19.i5.607
7. J.P.Issa. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004; 4:988-93; PMID:15573120; http://dx.doi.org/10.1038/nrc1507
8. P.A.Jones. Functions of DNA methylation:islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13:484-92; PMID:22641018; http://dx.doi.org/10.1038/nrg3230
9. X.Yang, H.Han, D.D.De Carvalho, F.D.Lay, P.A.Jones, G.Liang. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 2014; 26:577-90; PMID:25263941; http://dx.doi.org/10.1016/j.ccr.2014.07.028
10. S.Segditsas, I.Tomlinson. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006; 25:7531-7; PMID:17143297; http://dx.doi.org/10.1038/sj.onc.1210059
11. A.L.Silva, S.N.Dawson, M.J.Arends, K.Guttula, N.Hall, E.A.Cameron, T.H.Huang, J.D.Brenton, S.Tavaré, M.Bienz, et al. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. BMC Cancer 2014; 14:891; PMID:25432628; http://dx.doi.org/10.1186/1471-2407-14-891
12. Y.Z.Chen, D.Liu, Y.X.Zhao, H.T.Wang, Y.Gao, Y.Chen. Aberrant promoter methylation of the SFRP1 gene may contribute to colorectal carcinogenesis:a meta-analysis. Tumour Biol 2014; 35:9201-10; PMID:24929326; http://dx.doi.org/10.1007/s13277-014-2180-x
13. N.Vatandoost, J.Ghanbari, M.Mojaver, A.Avan, M.Ghayour-Mobarhan, R.Nedaeinia, R.Salehi. Early detection of colorectal cancer:from conventional methods to novel biomarkers. J Cancer Res Clin Oncol 2016; 142:341-51; PMID:25687380; http://dx.doi.org/10.1007/s00432-015-1928-z
14. A.Kalmár, B.Péterfia, P.Hollósi, B.Wichmann, A.Bodor, Á.V.Patai, A.Schöller, T.Krenács, Z.Tulassay, B.Molnár. Bisulfite-Based DNA methylation analysis from recent and archived formalin-fixed, paraffin embedded colorectal tissue samples. Pathol Oncol Res 2015; 21:1149-56; PMID:25991403; http://dx.doi.org/10.1007/s12253-015-9945-4
15. C.Sui, G.Wang, Q.Chen, J.Ma. Variation risks of SFRP2 hypermethylation between precancerous disease and colorectal cancer. Tumour Biol 2014; 35:10457-65; PMID:25053594; http://dx.doi.org/10.1007/s13277-014-2313-2
16. N.M.Samaei, Y.Yazdani, R.Alizadeh-Navaei, H.Azadeh, T.Farazmandfar. Promoter methylation analysis of WNT/β-catenin pathway regulators and its association with expression of DNMT1 enzyme in colorectal cancer. J Biomed Sci 2014; 21:73; PMID:25107489; http://dx.doi.org/10.1186/s12929-014-0073-3
17. Á.V.Patai, G.Valcz, P.Hollósi, A.Kalmár, B.Péterfia, Á.Patai, B.Wichmann, S.Spisák, B.K.Barták, K.Leiszter, et al. Comprehensive DNA methylation analysis reveals a common ten-gene methylation signature in colorectal adenomas and carcinomas. PLoS One 2015; 10:e0133836; PMID:26291085; http://dx.doi.org/10.1371/journal.pone.0133836
18. A.Kalmár, B.Péterfia, P.Hollósi, O.Galamb, S.Spisák, B.Wichmann, A.Bodor, K.Tóth, Á.V.Patai, G.Valcz, et al. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer. BMC Cancer 2015; 15:736; PMID:26482433; http://dx.doi.org/10.1186/s12885-015-1687-x
19. T.D.Silva, V.M.Vidigal, A.V.Felipe, J.M.DE Lima, R.A.Neto, S.S.Saad, N.M.Forones. DNA methylation as an epigenetic biomarker in colorectal cancer. Oncol Lett 2013; 6:1687-92; PMID:24260063; http://dx.doi.org/10.3892/ol.2013.1606
20. S.A.Farkas, V.Vymetalkova, L.Vodickova, P.Vodicka, T.K.Nilsson. DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genes. Epigenomics 2014; 6:179-91; PMID:24811787; http://dx.doi.org/10.2217/epi.14.7
21. H.Taniguchi, H.Yamamoto, T.Hirata, N.Miyamoto, M.Oki, K.Nosho, Y.Adachi, T.Endo, K.Imai, Y.Shinomura. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005; 24:7946-52; PMID:16007117; http://dx.doi.org/10.1038/sj.onc.1208910
22. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487:330-7; PMID:22810696; http://dx.doi.org/10.1038/nature11252
23. T.Murakami, H.Mitomi, T.Saito, M.Takahashi, N.Sakamoto, N.Fukui, T.Yao, S.Watanabe. Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum. Mod Pathol 2015; 28:146-58; PMID:24925057; http://dx.doi.org/10.1038/modpathol.2014.41
24. Q.J.Voorham, J.Janssen, M.Tijssen, S.Snellenberg, S.Mongera, N.C.van Grieken, H.Grabsch, M.Kliment, B.J.Rembacken, C.J.Mulder, et al. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas. BMC Cancer 2013; 13:603; PMID:24350795; http://dx.doi.org/10.1186/1471-2407-13-603
25. Y.Muto, T.Maeda, K.Suzuki, T.Kato, F.Watanabe, H.Kamiyama, M.Saito, K.Koizumi, Y.Miyaki, F.Konishi, et al. DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability. BMC Cancer 2014; 14:466; PMID:24964857; http://dx.doi.org/10.1186/1471-2407-14-466
26. Y.Fang, L.Wang, Y.Zhang, C.Ge, C.Xu. Wif-1 methylation and β-catenin expression in colorectal serrated lesions. Zhonghua Bing Li Xue Za Zhi 2014; 43:15-9; PMID:24713243; http://dx.doi.org/10.3760/cma.j.issn.0529-5807.2014.01.004
27. X.Fu, L.Li, Y.Peng. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum:possible roles and epigenetic regulatory mechanisms. J Clin Pathol 2012; 65:675-9; PMID:22412046; http://dx.doi.org/10.1136/jclinpath-2011-200602
28. Y.Luo, C.J.Wong, A.M.Kaz, S.Dzieciatkowski, K.T.Carter, S.M.Morris, J.Wang, J.E.Willis, K.W.Makar, C.M.Ulrich, et al. Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology 2014; 147:418-29; PMID:24793120; http://dx.doi.org/10.1053/j.gastro.2014.04.039
29. V.A.Naumov, E.V.Generozov, N.B.Zaharjevskaya, D.S.Matushkina, A.K.Larin, S.V.Chernyshov, M.V.Alekseev, Y.A.Shelygin, V.M.Govorun. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics 2013; 8:921-34; PMID:23867710; http://dx.doi.org/10.4161/epi.25577
30. Y.Zhao, J.Sun, H.Zhang, S.Guo, J.Gu, W.Wang, N.Tang, X.Zhou, J.Yu. High-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq. Clin Epigenetics 2014; 6:18; PMID:25276247; http://dx.doi.org/10.1186/1868-7083-6-18
31. T.De Meyer, P.Bady, G.Trooskens, S.Kurscheid, J.Bloch, J.M.Kros, J.A.Hainfellner, R.Stupp, M.Delorenzi, M.E.Hegi, et al. Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips:an independent large-scale comparison. Sci Rep 2015; 5:15375; PMID:26482909; http://dx.doi.org/10.1038/srep15375
32. S.Lee, N.Y.Cho, E.J.Yoo, J.H.Kim, G.H.Kang. CpG island methylator phenotype in colorectal cancers:comparison of the new and classic CpG island methylator phenotype marker panels. Arch Pathol Lab Med 2008; 132:1657-65; PMID:18834226; http://dx.doi.org/10.1043/1543-2165(2008)132[1657:CIMPIC]2.0.CO;2
33. D.J.Weisenberger, K.D.Siegmund, M.Campan, J.Young, T.I.Long, M.A.Faasse, G.H.Kang, M.Widschwendter, D.Weener, D.Buchanan, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38:787-93; PMID:16804544; http://dx.doi.org/10.1038/ng1834
34. B.A.Rodriguez, D.Frankhouser, M.Murphy, M.Trimarchi, H.H.Tam, J.Curfman, R.Huang, M.W.Chan, H.C.Lai, D.Parikh, et al. Methods for high-throughput MethylCap-Seq data analysis. BMC Genomics 2012; 13Suppl 6:S14; PMID:23134780; http://dx.doi.org/10.1186/1471-2164-13-S6-S14
35. O.Galamb, B.Wichmann, F.Sipos, S.Spisák, T.Krenács, K.Tóth, K.Leiszter, A.Kalmár, Z.Tulassay, B.Molnár. Dysplasia-carcinoma transition specific transcripts in colonic biopsy samples. PLoS One 2012; 7:e48547; PMID:23155391; http://dx.doi.org/10.1371/journal.pone.0048547
36. J.Sabates-Bellver, L.G.Van der Flier, M.de Palo, E.Cattaneo, C.Maake, H.Rehrauer, E.Laczko, M.A.Kurowski, J.M.Bujnicki, M.Menigatti, et al. Transcriptome profile of human colorectal adenomas. Mol Cancer Res 2007; 5:1263-75; PMID:18171984; http://dx.doi.org/10.1158/1541-7786.MCR-07-0267
37. T.Matsuyama, T.Ishikawa, K.Mogushi, T.Yoshida, S.Iida, H.Uetake, H.Mizushima, H.Tanaka, K.Sugihara. MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer. Int J Cancer 2010; 127:2292-9; PMID:20162577; http://dx.doi.org/10.1002/ijc.25256
38. A.Khamas, T.Ishikawa, K.Shimokawa, K.Mogushi, S.Iida, M.Ishiguro, H.Mizushima, H.Tanaka, H.Uetake, K.Sugihara. Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2′-deoxycytidine, microarray and gene expression profile. Cancer Genomics Proteomics 2012; 9:67-75; PMID:22399497; http://dx.doi.org/1109-6535/2012 $2.00+.40
39. H.Tang, Q.Guo, C.Zhang, J.Zhu, H.Yang, Y.L.Zou, Y.Yan, D.Hong, T.Sou, X.M.Yan. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition. Int J Mol Med 2010; 26:631-41; PMID:20878084; http://dx.doi.org/10.3892/ijmm_00000508
40. Y.Hong, T.Downey, K.W.Eu, P.K.Koh, P.Y.Cheah. A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis 2010; 27:83-90; PMID:20143136; http://dx.doi.org/10.1007/s10585-010-9305-4
41. S.Spisák, A.Kalmár, O.Galamb, B.Wichmann, F.Sipos, B.Péterfia, I.Csabai, I.Kovalszky, S.Semsey, Z.Tulassay, et al. Genome-wide screening of genes regulated by DNA methylation in colon cancer development. PLoS One 2012; 7:e46215; PMID:23049694; http://dx.doi.org/10.1371/journal.pone.0046215
42. K.Yagi, K.Akagi, H.Hayashi, G.Nagae, S.Tsuji, T.Isagawa, Y.Midorikawa, Y.Nishimura, H.Sakamoto, Y.Seto, et al. Three DNA methylation epigenotypes in human colorectal cancer. Clin. Cancer Res 2010; 16:21-33; PMID:20028768; http://dx.doi.org/10.1158/1078-0432.CCR-09-2006
43. X.Xu, Y.Zhang, J.Williams, E.Antoniou, W.R.McCombie, S.Wu, W.Zhu, N.O.Davidson, P.Denoya, E.Li. Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets. BMC Bioinformatics 2013; 14Suppl 9:S1; PMID:23902433; http://dx.doi.org/10.1186/1471-2105-14-S9-S1
44. R.Exner, W.Pulverer, M.Diem, L.Spaller, L.Woltering, M.Schreiber, B.Wolf, M.Sonntagbauer, F.Schröder, J.Stift, F.Wrba, M.Bergmann, A.Weinhäusel, G.Egger. Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers. Br J Cancer 2015; 113:1035-45; PMID:26335606; http://dx.doi.org/10.1038/bjc.2015.303
45. K.Tóth, F.Sipos, A.Kalmár, A.V.Patai, B.Wichmann, R.Stoehr, H.Golcher, V.Schellerer, Z.Tulassay, B.Molnár. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS One 2012; 7:e46000; http://dx.doi.org/10.1371/journal.pone.0046000
46. J.Ernst, P.Kheradpour, T.S.Mikkelsen, N.Shoresh, L.D.Ward, C.B.Epstein, X.Zhang, L.Wang, R.Issner, M.Coyne, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011; 473:43-9; PMID:21441907; http://dx.doi.org/10.1038/nature09906
47. A.Syed Sameer, Z.A.Shah, S.Abdullah, N.A.Chowdri, M.A.Siddiqi. Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population. Hum Genomics 2011; 5:441-52; PMID:21807601; http://dx.doi.org/10.1186/1479-7364-5-5-441
48. H.Judson, A.Stewart, A.Leslie, N.R.Pratt, D.U.Baty, R.J.Steele, F.A.Carey. Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas. J Pathol 2006; 210:344-50; PMID:16902913; http://dx.doi.org/10.1002/path.2044
49. Z.Q.Wu, T.Brabletz, E.Fearon, A.L.Willis, C.Y.Hu, X.Y.Li, S.J.Weiss. Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity. Proc Natl Acad Sci USA 2012; 109:11312-7; PMID:22745173; http://dx.doi.org/10.1073/pnas.1203015109
50. Y.Wang. Wnt/Planar cell polarity signaling:a new paradigm for cancer therapy. Mol Cancer Ther 2009; 8:2103-9; PMID:19671746; http://dx.doi.org/10.1158/1535-7163.MCT-09-0282
51. T.S.Gujral, M.Chan, L.Peshkin, P.K.Sorger, M.W.Kirschner, G.MacBeath. A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis. Cell 2014; 159:844-56; PMID:25417160; http://dx.doi.org/10.1016/j.cell.2014.10.032
52. D.W.Chan, C.Y.Chan, J.W.Yam, Y.P.Ching, I.O.Ng. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. Gastroenterology 2006; 131:1218-27; PMID:17030191; http://dx.doi.org/10.1053/j.gastro.2006.07.020
53. R.Najdi, R.F.Holcombe, M.L.Waterman. Wnt signaling and colon carcinogenesis:beyond APC. J Carcinog 2011; 10:5; PMID:21483657; http://dx.doi.org/10.4103/1477-3163.78111
54. D.Ahmed, P.W.Eide, I.A.Eilertsen, S.A.Danielsen, M.Eknæs, M.Hektoen, G.E.Lind, R.A.Lothe. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2013; 2:e71; PMID:24042735; http://dx.doi.org/10.1038/oncsis.2013.35
55. J.Y.Fang, J.Lu, Y.X.Chen, L.Yang. Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines. World J Gastroenterol 2003; 9:1976-80; PMID:12970888; http://dx.doi.org/10.3748/wjg.v9.i9.1976
56. K.Hagiwara, H.Ito, T.Murate, Y.Miyata, H.Ohashi, H.Nagai. PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation. Genes Chromosomes Cancer 2012; 51:1024-36; PMID:22833470; http://dx.doi.org/10.1002/gcc.21985
57. H.Suzuki, E.Gabrielson, W.Chen, R.Anbazhagan, M.van Engeland, M.P.Weijenberg, J.G.Herman, S.B.Baylin. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31:141-9; PMID:11992124; http://dx.doi.org/10.1038/ng892
58. L.Laurent, E.Wong, G.Li, T.Huynh, A.Tsirigos, C.T.Ong, H.M.Low, K.W.Kin Sung, I.Rigoutsos, J.Loring, et al. Dynamic changes in the human methylome during differentiation. Genome Res 2010; 20:320-31; PMID:20133333; http://dx.doi.org/10.1101/gr.101907.109
59. S.Lou, H.M.Lee, H.Qin, J.W.Li, Z.Gao, X.Liu, L.L.Chan, V.Kl Lam, W.Y.So, Y.Wang, et al. Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation. Genome Biol 2014; 15:408; PMID:25074712; http://dx.doi.org/10.1186/s13059-014-0408-0
60. Y.Wang, R.R.Jadhav, J.Liu, D.Wilson, Y.Chen, I.M.Thompson, D.A.Troyer, J.Hernandez, H.Shi, R.J.Leach, T.H.Huang, V.X.Jin. Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis. Sci Rep 2016; 6:22051; PMID:26924343; http://dx.doi.org/10.1038/srep22051
61. Diagenode. Innovating Epigenetic Solutions. http://www.diagenode.com/media/catalog/file/MethylCap_kit_manual.pdf
62. B.Langmead, S.L.Salzberg. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9:357-9; PMID:22388286; http://dx.doi.org/10.1038/nmeth.1923
63. National Center for Biotechnology Information. http://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.13/
64. H.Li, B.Handsaker, A.Wysoker, T.Fennell, J.Ruan, N.Homer, G.Marth, G.Abecasis, R.Durbin. 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25:2078-9; PMID:19505943; http:dx.doi.org/10.1093/bioinformatics/btp352
65. L.Chavez, M.Lienhard, J.Dietrich. MEDIPS:(MeD)IP-seq data analysis. R package version 1.14.0. 2013
66. Á.V.Patai, B.K.Barták, B.Péterfia, T.Micsik, R.Horváth, C.Sumánszki, Z.Péter, Á.Patai, G.Valcz, A.Kalmár, et al. Comprehensive DNA methylation and mutation analyses reveal a methylation signature in colorectal sessile serrated adenomas. Pathol Oncol Res 2016 (in press)